Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K G Terkelsen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Family Process|June 1, 1983
Schizophrenia and the family: II. Adverse effects of family therapyK G Terkelsen
The American Journal of Psychiatry|January 1, 1984
Mania after surreptitious discontinuation of clonidineK G Terkelsen
The American Journal of Psychiatry|December 1, 1985
Benefits of correlating neuroleptic blood level and auditory distractibilityK G Terkelsen
Pharmacoeconomics|August 6, 1995
Measuring the costs of schizophrenia. Implications for the post-institutional era in the USK G Terkelsen, A Menikoff
Hospital & Community Psychiatry|August 1, 1990
Estimating clozapine's cost to the nationK G Terkelsen, R C Grosser
Journal of Clinical Psychopharmacology|August 1, 1994
Esophageal dysfunction in two patients after clozapine treatmentR H McCarthy, K G Terkelsen
Pharmacopsychiatry|March 1, 1995
Risperidone augmentation of clozapineR H McCarthy, K G Terkelsen
Community Mental Health Journal|June 1, 1994
Home visits in the era of cost containment: comments on Reding, Raphelson and Montgomery's paperK G Terkelsen, R H McCarthy
Archives of General Psychiatry|June 1, 1992
Long-term outcome in chronic schizophreniaF Schwartz, K G Terkelsen, T E Smith
Bulletin of the Menninger Clinic|January 1, 1993
The role of personality in the treatment of schizophrenic and schizoaffective disorder inpatients: a pilot studyT E Smith, A Deutsch, F Schwartz, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Family Process|June 1, 1983
Schizophrenia and the family: II. Adverse effects of family therapyK G Terkelsen
The American Journal of Psychiatry|January 1, 1984
Mania after surreptitious discontinuation of clonidineK G Terkelsen
The American Journal of Psychiatry|December 1, 1985
Benefits of correlating neuroleptic blood level and auditory distractibilityK G Terkelsen
Pharmacoeconomics|August 6, 1995
Measuring the costs of schizophrenia. Implications for the post-institutional era in the USK G Terkelsen, A Menikoff
Hospital & Community Psychiatry|August 1, 1990
Estimating clozapine's cost to the nationK G Terkelsen, R C Grosser
Journal of Clinical Psychopharmacology|August 1, 1994
Esophageal dysfunction in two patients after clozapine treatmentR H McCarthy, K G Terkelsen
Pharmacopsychiatry|March 1, 1995
Risperidone augmentation of clozapineR H McCarthy, K G Terkelsen
Community Mental Health Journal|June 1, 1994
Home visits in the era of cost containment: comments on Reding, Raphelson and Montgomery's paperK G Terkelsen, R H McCarthy
Archives of General Psychiatry|June 1, 1992
Long-term outcome in chronic schizophreniaF Schwartz, K G Terkelsen, T E Smith
Bulletin of the Menninger Clinic|January 1, 1993
The role of personality in the treatment of schizophrenic and schizoaffective disorder inpatients: a pilot studyT E Smith, A Deutsch, F Schwartz, et al.
Pageof 2